$1.29
-0.06-4.44%
Last update: Oct 30, 4:00 PM
Cibus Inc (CBUS) Stock Price, Quote, News & History
CBUSNASDAQ
Shares of Navan Inc (NASDAQ: NAVN) spiked in pre-market trading on better-than-expected Q4 results. Gainers include EEIQ, FCHL, OLPX, SLND, PGEN, EDHL, NFGC,...
You can purchase shares of Cibus (NASDAQ:CBUS) through any online brokerage.
Other companies in Cibus’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Cibus has a consensus price target of $16.63.
The stock price for Cibus (NASDAQ: CBUS) is $1.3 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Cibus.
Cibus does not have any upcoming earnings scheduled.
There is no upcoming split for Cibus.
Cibus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The...
